Media center

LATEST NEWS

Statement from Mundipharma on COVID-19

20 Mar 2020

Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency

22 Aug 2019

FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA

Mundipharma announces exclusive license and supply agreement with Prestige Biopharma for Tuznue® (HD201)

2 Jul 2019

FOR EUROPEAN BUSINESS/TRADE MEDIA ONLY

Invokana® (canagliflozin) Significantly Reduced Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in New CREDENCE Analysis

11 Jun 2019

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

MEDIA RESOURCES

LATEST VIDEOS